Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studyJoëlle Vermeulen, Jo Vandesompele, Katleen De Preter et al.|The Lancet Oncology|2009Cited by 196
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALLFlorian Babor, Roland Meisel, Tobias Feuchtinger et al.|Bone Marrow Transplantation|2019Cited by 21
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUMKrzysztof Kałwak, Franco Locatelli, Laura M. Moser et al.|Blood Advances|2024Cited by 3
Moderate Incidence but Striking Correlation with TBI of Secondary Malignancies after HSCT in Children with ALL: Long-Term Follow-up from the Prospective International BFM- and Forum-TrialsÁnita Lawitschka, Peter Bader, Jean‐Hugues Dalle et al.|Blood|2023Cited by 2